By Jeffrey May, J.D.
A federal court considering a case in which foreign law is relevant is not bound to defer to an official interpretation of the law offered by the foreign government, a unanimous Supreme Court announced today. "A federal court should accord respectful consideration to a foreign government’s submission, but is not bound to accord conclusive effect to the foreign government’s statements," the Court held in an opinion written by Justice Ruth Bader Ginsburg. A decision of the U.S. Court of Appeals in New York City that a federal court was bound to defer to an interpretation offered by a foreign government that "directly participates in U.S. court proceedings" that is "reasonable under the circumstances" was vacated (Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd., June 14, 2018, Ginsburg, R.).
The case involved a price fixing action against Chinese manufacturers and exporters of vitamin C. U.S.-based purchasers of vitamin C alleged that Chinese sellers had formed a cartel "facilitated by the efforts of their trade association," the Chamber of Commerce of Medicines and Health Products Importers and Exporters.
The defending Chinese sellers argued that the claims should be rejected on the ground that Chinese law required them to fix the price and quantity of vitamin C exports. They contended that they were shielded from antitrust liability by the act of state doctrine, the foreign sovereign compulsion doctrine, and principles of international comity. The Ministry of Commerce of the People’s Republic of China filed a brief as amicus curiaein support of the Chinese sellers.
The district court rejected the defendants’ contentions and allowed the case to go to a jury. The jury found that the Chinese sellers had fixed prices and were not "actually compelled" by China to enter into those agreements. The jury awarded more than $54 million before trebling. On appeal, the Second Circuit reversed.
The appellate court applied a "highly deferential standard," according to the Supreme Court. The appellate court’s decision that Chinese law required the Chinese sellers to engage in the challenged conduct was based solely on the statements of the Ministry of Commerce. According to the Supreme Court, the Second Circuit panel disregarded the submissions made by the U.S. purchasers casting doubt on the foreign government’s submission.
Federal Rule of Civil Procedure 44.1 specifies that a court’s determination of foreign law "must be treated as a ruling on a question of law," rather than as a finding of fact, the Supreme Court explained. However, Rule 44.1 does not address the weight a federal court determining foreign law should give to the views presented by the foreign government.
The High Court pointed out that "no single formula or rule will fit all cases in which a foreign government describes its own law." It was error, however, for the appellate court to deem the submission of the Ministry of Commerce as binding, so long as facially reasonable. The High Court called this approach an "unyielding rule [that] is inconsistent with Rule 44.1."
Reciprocity concerns. The High Court also noted that the appellate court’s concern for reciprocity was sound but did not warrant the judgment. "[T]he United States, historically, has not argued that foreign courts are bound to accept its characterizations or precluded from considering other relevant sources," the Court said. Two international treaties that establish formal mechanisms by which one government may obtain from another an official statement characterizing its laws also support the approach that a foreign government’s view of its own law is ordinarily entitled to substantial but not conclusive weight, it was noted.
Remand. The Supreme Court remanded the matter for renewed consideration in light of its decision. The appellate court had failed to consider the shortcomings in the submission by the Ministry of Commerce identified by the district court. "[T]he materials identified by the District Court were at least relevant to the weight the Ministry’s submissions should receive and to the question whether Chinese law required the Chinese sellers’ conduct," the High Court concluded.
Impact. The decision will assist enforcement of U.S. antitrust laws. It is helpful for antitrust plaintiffs, such as the petitioners here, seeking to recover from participants in global cartels. Rejection of the Second Circuit’s standard also is beneficial to antitrust enforcement authorities. Further, the decision will likely have a deterrent effect on foreign entities participating in global cartels that would have otherwise been shielded under a more deferential standard. The U.S. Department of Justice had filed an amicus brief and participated in oral argument in the case, supporting the petitioners.
Attorneys: Michael Julian Gottlieb (Boies Schiller Flexner LLP) for Animal Science Products, Inc. Jonathan M. Jacobson (Wilson Sonsini Goodrich & Rosati, PC) for Hebei Welcome Pharmaceutical Co., Ltd.
Companies: Animal Science Products, Inc.; Hebei Welcome Pharmaceutical Co., Ltd.
MainStory: TopStory Antitrust
Interested in submitting an article?
Submit your information to us today!Learn More